StockGlow

Lakefront Biotherapeutics NV (GXE.F)

Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe.

24.06+0.01%Healthcare
Compare GXE.F with
StockGlow Score
14
Bearish
BearishBullish
1 year ago-14.7%

The outlook

Lakefront Biotherapeutics NV currently reads as bearish based on below its 50- & 200-day averages, 16% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range16% of the way from its 52-week low to high
Market cap
$1.58B
52-wk high
31.86
52-wk low
22.56
50-day avg
24.87
200-day avg
26.22
Trailing P/E
3.2

Similar stocks

GXEA.FLakefront Biotherapeutics NV$24.00+0.00%DR6.FACADIA Pharmaceuticals Inc.$23.02+0.61%UP0.FUltragenyx Pharmaceutical Inc.$22.52+4.89%38I.FIntellia Therapeutics, Inc.$9.30+1.53%2L9.FVisionWave Holdings, Inc.$1.63-3.66%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy